Search results

1. Photodynamic inactivation as a broad-spectrum antibiotic adjuvant reversing multidrug-resistant Gram-negative critical p…

Principal investigator: dr hab. Mariusz Stanisław Grinholc

Uniwersytet Gdański

Call: OPUS 29, Panel: NZ7

2. Systematic analysis of antimicrobial resistance profiles and resistance spread in a diverse bacterial and phage communit…

Principal investigator: dr hab. Anna Różańska

Uniwersytet Jagielloński

Call: SHENG 4, Panel: NZ2

3. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

Principal investigator: dr Michał Jerzy Woźniak

Uniwersytet Medyczny w Łodzi

Call: OPUS 28, Panel: NZ7

4. Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap…

Principal investigator: prof. Jarosław Piotr Czyż

Uniwersytet Jagielloński

Call: OPUS 28, Panel: NZ3

5. A new universal method for the isolation and deep proteomic characterization of extracellular vesicles to study drug res…

Principal investigator: Bianka Świderska

Instytut Biochemii i Biofizyki PAN

Call: PRELUDIUM 23, Panel: NZ2

6. Exploiting the weakness of lymphoma: spectroscopic identification of biomarkers for lymphoma metabolism and inducing its…

Principal investigator: Patrycja Dawiec

Uniwersytet Jagielloński

Call: PRELUDIUM 23, Panel: ST4

7. Evaluation of the role of miRNA as a peripheral biomarker of drug resistance in epilepsy using biosensors for electroche…

Principal investigator: dr hab. Janusz Szyndler

Warszawski Uniwersytet Medyczny

Call: OPUS 27, Panel: NZ5

8. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista…

Principal investigator: prof. Mariusz Papp

Instytut Farmakologii PAN

Call: OPUS 26, Panel: NZ7

9. Directed screening and evaluation of novel bactericidal compounds active againsttubercle bacilli and Mycobacterium absce…

Principal investigator: prof. Jarosław Dziadek

Instytut Biologii Medycznej PAN

Call: OPUS 25, Panel: NZ7

10. INVADOPODIA IN AXL-DRIVEN CANCER INVASION AND DRUG RESISTANCE

Principal investigator: dr Daria Paulina Zdżalik-Bielecka

Uniwersytet Warszawski, Wydział Biologii

Call: OPUS 25, Panel: NZ3

11. Bis(benzosiloxaboroles) as a new class of potential antibiotics - a perspective solution to growing problem of antimicro…

Principal investigator: Krzysztof Nowicki

Politechnika Warszawska, Wydział Chemiczny

Call: PRELUDIUM 22, Panel: ST5

12. Plant bacterial endophytes as an important antibiotic-resistance dissemination vector

Principal investigator: dr Magdalena Marta Zalewska

Uniwersytet Warszawski, Wydział Biologii

Call: SONATA 18, Panel: NZ9

13. Regulatory network and interactome of inner membrane drug/metabolite transporters in bacteria – implications for physiol…

Principal investigator: dr hab. Aneta Agnieszka Bartosik

Instytut Biochemii i Biofizyki PAN

Call: OPUS 23, Panel: NZ2

14. Role of natural products in overcoming drug resistance in Mycobacterium tuberculosis

Principal investigator: dr Elwira Zofia Sieniawska

Uniwersytet Medyczny w Lublinie

Call: OPUS 23, Panel: NZ7

15. Reserved antibiotics and critical priority pathogens in hospital wastewater as an indicator of sanitary-epidemiological …

Principal investigator: prof. Ewa Korzeniewska

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

Call: OPUS 23, Panel: NZ7

16. The role of Candida albicans' plasma membrane sphingolipids in the potentially new mechanism of drug resistance and in t…

Principal investigator: dr hab. Anna Janina Krasowska

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: OPUS 22, Panel: NZ1

17. Impact of condensate in air-conditioning systems on secondarymicrobiological pollution of indoor air.

Principal investigator: dr hab. Katarzyna Piekarska

Politechnika Wrocławska

Call: OPUS 21, Panel: ST8

18. Propolis and polyphenols derived from this product as potential antifungal agents

Principal investigator: dr hab. Piotr Szweda

Politechnika Gdańska

Call: OPUS 20, Panel: NZ7

19. The role of vitamin D receptor in 5-fluorouracil responsiveness of colorectal cancer cells

Principal investigator: dr Magdalena - Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATA 16, Panel: NZ5

20. Epidemiology and rapid spread of antimicrobial resistance amongAcinetobacter spp. strains in hospital units - analysis u…

Principal investigator: dr hab. Agnieszka Chmielarczyk

Uniwersytet Jagielloński, Collegium Medicum

Call: PRELUDIUM BIS 2, Panel: NZ7

21. Digestate from agricultural biogas plants as a reservoir of drug-resistance – a real risk to the environment?

Principal investigator: Izabela Wolak

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

Call: PRELUDIUM 19, Panel: NZ9

22. Multivariable biostatistical model based on in vitro methods for prediction of anthelmintic resistance in goats.

Principal investigator: prof. Jarosław Feliks Kaba

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Medycyny Weterynaryjnej

Call: OPUS 19, Panel: NZ6

23. Effect of the co-treatment of municipal wastewater and landfill leachate on the spread of ARGs in the environment

Principal investigator: Małgorzata Czatzkowska

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

Call: PRELUDIUM 19, Panel: NZ9

24. Zinc deficient diet as a trigger for treatment-resistant depression in chronically stressed mice. Understanding the mech…

Principal investigator: dr hab. Bernadeta Szewczyk

Instytut Farmakologii PAN

Call: OPUS 19, Panel: NZ5

25. Assessment of therapeutic value and usefulness of new generation antibiotics and their metabolites as resistance markers…

Principal investigator: Katarzyna Joanna Pauter-Iwicka

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Call: PRELUDIUM 19, Panel: ST4

26. The use of evolutionary patterns in the optimization of chemotherapy of tuberculosis

Principal investigator: dr Alina Ewa Minias

Instytut Biologii Medycznej PAN

Call: SONATA BIS 9, Panel: NZ6

27. The use of olaparib and ATR / CHK1 kinase inhibitors as a targeted anti-cancer therapy based on synthetic lethality

Principal investigator: dr hab. Aneta Katarzyna Rogalska

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: SONATA BIS 9, Panel: NZ7

28. Concomitant IDentification and Antibiotic REsistance profile of bacteria in one hour with an adaptive targeted single Ma…

Principal investigator: prof. Marek Tomasz Gniadkowski

Narodowy Instytut Leków

Call: JPIAMR2019, Panel: NZ6

29. Implementing molecular models for the HIV and HCV transmission networks and resisistance surveillance to inform clinical…

Principal investigator: prof. Miłosz Parczewski

Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Medycyny

Call: SONATA BIS 8, Panel: NZ6

30. Molecular determinants of drug resistance influenza virus causing infection in humans in diffrent epidemic seasons in Po…

Principal investigator: dr Ewelina Maria Hallmann

Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

Call: PRELUDIUM 15, Panel: NZ7

31. Genomic insights into the mechanisms of drug resistance, virulence and transmission of Mycobacterium tuberculosis strain…

Principal investigator: dr Tomasz Jagielski

Uniwersytet Warszawski, Wydział Biologii

Call: DAINA 1, Panel: NZ6

32. Resistance of environmental microorganisms in the perspective of holistic "One Health" approach

Principal investigator: dr hab. Ewa Korzeniewska

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

Call: OPUS 14, Panel: NZ9

33. Study on metabolism of microorganisms treated with metal nanoparticles, antibiotics, metal ions and their combinations u…

Principal investigator: Agnieszka Maria Rogowska

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Call: PRELUDIUM 13, Panel: ST4

34. Molecular and pharmacological approaches based on inhibition of glycolysis to overcome de novo- and antiangiogenic thera…

Principal investigator: dr hab. Beata Teresa Pająk

Wojskowy Instytut Higieny i Epidemiologii im. gen. Karola Kaczkowskiego

Call: OPUS 13, Panel: NZ3

35. Studies of the role of toxin-antitoxin systems in antibiotics resistance in staphylococci.

Principal investigator: dr hab. Benedykt Władyka

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 13, Panel: NZ6

36. Changes in Candida albicans drug resistance and virulence in responce to different carbon sources

Principal investigator: dr hab. Anna Janina Krasowska

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: OPUS 12, Panel: NZ1

37. The use of bioaugmentation to intesification of biogas production from organic substrates with concentration of antimicr…

Principal investigator: dr hab. Monika Daria Harnisz

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

Call: OPUS 12, Panel: NZ9

38. Dynamics of antibioctic resistance changes among bacteria in sewage tratment systems using activated sludge

Principal investigator: Adriana Dorota Osińska

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

Call: PRELUDIUM 12, Panel: NZ9

39. Mathematical modelling of drug resistance in anticancer therapies.

Principal investigator: dr Mariusz Piotr Bodzioch

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Matematyki i Informatyki

Call: PRELUDIUM 12, Panel: ST1

40. Environmental anaerobic bacteria of the Bacteroides fragilis group - pioneering research

Principal investigator: Sebastian Niestępski

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

Call: PRELUDIUM 12, Panel: NZ9

41. Old drugs - new perspectives: modulation of antibiotics activity by caffeine and pentoxifylline

Principal investigator: dr Anna Woziwodzka

Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Call: SONATA 11, Panel: NZ7

42. Importance of cyclin F-RRM2 axis in drug-resistance of melanoma cells with different degree of aggressiveness - in vitro…

Principal investigator: prof. Alina Grzanka

Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Lekarski

Call: OPUS 11, Panel: NZ7

43. Epidemiology of metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in Poland over the last deca…

Principal investigator: prof. Marek Tomasz Gniadkowski

Narodowy Instytut Leków

Call: OPUS 11, Panel: NZ7

44. Characterization and improvement of anti-cancer properties of second generation antagonists of Mdm2 oncoprotein

Principal investigator: dr Łukasz Skalniak

Uniwersytet Jagielloński, Wydział Chemii

Call: SONATA 11, Panel: NZ7

45. Characterization of aberrant mechanisms of telomere maintenance in chronic myeloid leukemia - the role of POT1 and RAP1 …

Principal investigator: dr Tomasz Artur Stokłosa

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 10, Panel: NZ5

46. The evaluation of electroporation and electrochemotherapy activity in human cancer cells sensitive and resistant to chem…

Principal investigator: dr Nina Rembiałkowska

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski

Call: PRELUDIUM 10, Panel: NZ7

47. Analysis of mechanisms of drug resistance to trastuzumab in HER2 overexpressing breast cancer based on gene expression c…

Principal investigator: Anna Maria Rusek

Uniwersytet Medyczny w Białymstoku, Wydział Lekarski z Oddziałem Stomatologii i Oddziałem Nauczania w Języku Angielskim

Call: PRELUDIUM 9, Panel: NZ2

48. Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h…

Principal investigator: Zofia Felicja Bielecka

Wojskowy Instytut Medyczny

Call: PRELUDIUM 9, Panel: NZ5

49. Role of the selected anti-tumor agents transported by electropermeabilization to the drug-sensitive and drug-resistant c…

Principal investigator: dr Joanna Barbara Weżgowiec

Politechnika Wrocławska, Wydział Podstawowych Problemów Techniki

Call: PRELUDIUM 8, Panel: NZ7

50. Identification of new, clinically relevant genetic and epigenetic aberrations by next-generation sequencing in chronic m…

Principal investigator: dr Tomasz Artur Stokłosa

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Call: HARMONIA 6, Panel: NZ5

Projects search